跳至主要内容
临床试验/NCT04035707
NCT04035707已完成不适用

Serum Tryptase Concentration During General Anaesthesia With Rocuronium

Medical University of Bialystok0 个研究点目标入组 126 人开始时间: 2009年6月25日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
126
主要终点
tryptase

研究概览

简要总结

Rocuronium is a aminosteroid structured, non-depolarizing neuromuscular blocking agents (NMB). Epidemiological data presents that the frequency of hypersensitivity reactions caused by rocuronium have been increased. Determinations of serum tryptase concentrations are interdisciplinary recommended in diagnosis of its adverse reactions. No studies have been performed to explain specific role of rocuronium doses on serum tryptase values. The aim of this study was to investigate the potential effect of rocuronium on serum tryptase concentrations.

详细描述

The greatest risk of hypersensitivity occurs during anesthesia for female patients and it is connected with the induction phase using skeletal muscle relaxants . Epidemiological data presents that the frequency of hypersensitivity reactions caused by rocuronium have been increased. Due to the multiple advantages reports of triggering allergic or hypersensitivity reactions caused by rocuronium create doubts about the safety of application .

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Investigator)

盲法说明

qualification according surgical operation

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • ASA 1-2, no allergy and perioperative hypersensitivity reactions during anaesthesia

排除标准

  • steroid therapy, allergy in medical history, mastocytosis

研究组 & 干预措施

anaesthesia with rocuronium

Experimental

rocuronium is used during anaesthesia

干预措施: Rocuronium (Drug)

anaesthesia with rocuronium

Experimental

rocuronium is used during anaesthesia

干预措施: general volatile anaesthesia (Drug)

anaesthesia without rocuronium

Experimental

during anaesthesia rocuronium is not used

干预措施: general volatile anaesthesia (Drug)

结局指标

主要结局

tryptase

时间窗: up to 40 minutes after surgery

serum tryptase concentration

次要结局

未报告次要终点

研究者

发起方
Medical University of Bialystok
申办方类型
Other
责任方
Sponsor

相似试验